{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:40:25Z","timestamp":1770068425461,"version":"3.49.0"},"reference-count":22,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":8133,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1990,12]]},"abstract":"<jats:p><jats:italic>Benazepril hydrochloride (CGS 14824A) is an orally active, nonsulfhydryl compound that is transformed in vivo to a long\u2010acting inhibitor of angiotensin\u2010converting enzyme (ACE). Previous studies have shown benazepril to lower blood pressure in hypertensive patients and to confer acute hemodynamic benefits in patients with congestive heart failure (CHF). In the current multicenter investigation, 16 patients with chronic CHF due to left ventricular systolic dysfunction (ejection fraction &lt; 0.40 at rest) whose symptoms corresponded to New York Heart Association classes II to IV were given open\u2010label benazepril once daily in ascending doses of 2 to 20 mg and followed biweekly for 12 weeks. Evaluation of the 15 subjects who completed the trial showed a progressive increase in treadmill exercise duration (from 7.65 \u00b1 3.64<\/jats:italic> [<jats:italic>SD<\/jats:italic>] <jats:italic>minutes at baseline to 9.74 \u00b1 3.66 minutes at 12 weeks<\/jats:italic>, P &lt; .001); <jats:italic>augmentation of the mean left ventricular ejection fraction (from 0.266 \u00b1 0.133 at baseline to 0.292 \u00b1 0.136 at 12 weeks<\/jats:italic>, P &lt; .025); <jats:italic>relief of exertional dyspnea in 7 of the 15 patients<\/jats:italic> (P &lt; .02); <jats:italic>and improvement in global symptomatic status in 10 of the patients<\/jats:italic> (P &lt; .01). <jats:italic>These responses were accompanied by a reduction in serum ACE activity of 75% (from 27.2 \u00b1 10.5 IU\/L at baseline to 6.7 \u00b1 1.9 IU\/L at 12 weeks<\/jats:italic>, P &lt; .001), <jats:italic>which was independent of dose and duration of treatment. The magnitude of ACE inhibition did not correlate with changes in the efficacy variables. Aside from two instances of symptomatic hypotension (one of which was complicated by volume depletion), the drug was well tolerated. Long\u2010term therapy with benazepril for patients with CHF shows promise. A large\u2010scale, double\u2010blind trial of benazepril in this population is currently in progress<\/jats:italic>.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1990.tb01853.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T21:45:35Z","timestamp":1362779135000},"page":"1106-1111","source":"Crossref","is-referenced-by-count":9,"title":["Long\u2010Term Therapy with Benazepril in Patients with Congestive Heart Failure: Effects on Clinical Status and Exercise Tolerance"],"prefix":"10.1002","volume":"30","author":[{"given":"Hillel S.","family":"Ribner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran B.","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Glasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann\u2010Ming","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia V.","family":"Dills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Larkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Whalen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197907193010301"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.69.3.548"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(85)80269-2"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(83)80316-7"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.70.2.271"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706043162301"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00148a023"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00543322"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541289"},{"key":"e_1_2_1_11_2","unstructured":"WhalenJJ GourleyLA:Diurnal blood pressure response to benzazepril new angiotensin\u2010converting enzyme inhibitor in mild to moderate essential hypertension. Presented at the Second Annual Meeting of the American Society of Hypertension New York NY May 1621 1987."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90762-X"},{"key":"e_1_2_1_13_2","first-page":"45A","article-title":"Peak and trough effects of three once daily dose levels of benazepril in mild\u2010moderate hypertension","volume":"2","author":"Whalen J","year":"1989","journal-title":"Am J Hyperten"},{"key":"e_1_2_1_14_2","volume-title":"Effectiveness of twice\u2010daily CGS 14824A for control of mild\u2010to\u2010moderate essential hypertension","author":"Whalen JJ","year":"1988"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1989.34"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90772-1"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-29-10-1349"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(75)90395-2"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-30-5-682"},{"key":"e_1_2_1_20_2","first-page":"240","article-title":"Two potent angiotensin\u2010converting enzyme (ACE) inhibitors: CGS 14824A and CGS 14831","volume":"25","author":"Chen D\u2010S","year":"1983","journal-title":"Pharmacologist"},{"key":"e_1_2_1_21_2","first-page":"102","article-title":"Antihypertensive assessment of CGS 14824A, an orally effective angiotensin\u2010converting enzyme (ACE) inhibitor","volume":"25","author":"Miller D","year":"1983","journal-title":"Pharmacologist"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02602.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01151.x"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1990.tb01853.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1990.tb01853.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T07:09:10Z","timestamp":1697958550000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1990.tb01853.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["10.1002\/j.1552-4604.1990.tb01853.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1990.tb01853.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}